Salt Lake City-based biotech company PolarityTE Inc.  has announced that its board of directors has created an “office of the chief executive” to run the company. The office will consist of a team of three senior executives who will focus and collaborate on commercialization, operational and financial performance and new product development. Members of the office of the chief executive include Richard Hague, chief operating officer; Paul Mann, chief financial officer; and David Seaburg, president of corporate development. Denver Lough remains the chairman of the board and continues on indefinite administrative leave from the offices of CEO and chief research and development officer.

The rest of this article is only available to our online subscribers. Please log in, or click here to subscribe.

Pin It